PlanetConnect
Founded 1994
About PlanetConnect
PlanetConnect has over 25 years of experience in producing custom research events in the Pharma, Telecom, and AgBio sectors. These events bring up to 5000 internal R&D staff to a private 1 - 4 day event, where attendees interact in a secure, proprietary environment at an outside hotel/resort. Companies that outsource events to PlanetConnect in Pharmaceutical/Biotech include BMS, GlaxoSmithKline, J&J, Merck, Biogen, Sanofi, Novartis and Pfizer. These events can encompass Research, Development, PreClinical, Clinical, Manufacturing, Drug Delivery and Diagnostics, IT and Innovation. Upcoming events at: http://events.planetconnect.com In addition to a full schedule of talks, poster sessions, networking devices and applications, streaming and on-demand video, and attendee networking, PlanetConnect provides well-known, respected outside speakers and up to 250 approved exhibitors. PlanetConnect has over 2,000 active partner/customer companies in it's qualified portfolio with over 1,500 such companies participating in events. PlanetConnect has a unique set of networking tools and devices for large research events, including iPhone/Android platforms and social networking tools. Provide business development and technical project development to a wide range of companies, such as Deutsche Bank (Single Sign On enterprise development and product spinoffs); managed ten contract developers provided to Lucent Technologies for a number of forward looking wireless broadband development projects. Sit on Boards and provide funds for a number of ventures and growing companies. PlanetConnect is a certified Women Owned Business.
Company Facts
- Founded: 1994
- Legal name: PlanetConnect, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Website: planetconnect.com
- Phone: 1-732-933-9473
Social Profiles
Canonical: https://fsome.com/organization/planetconnect-8281518 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.